Some good news in our race for a COVID-19 vaccine. Both Johnson & Johnson and Astrazeneca have announced they’re resuming phase 3 trials for their respective COVID vaccines.
AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week, the companies said on..
Here's the latest on the coronavirus pandemic.
![Daily Covid-19 Minute: Astrazeneca’s Vaccine Trial Has Been On Pause For 6 Weeks, Here’s What We Know [Video]](https://video.newsserve.net/300/v/20201027/2010271317-Daily-Covid-19-Minute-Astrazeneca-Vaccine-Trial.jpg)
![J&J, AstraZeneca resuming trials of vaccines [Video]](https://video.newsserve.net/300/v/20201024/2010242041-AstraZeneca-resuming-trials-of-vaccines.jpg)
![Moderna Finishes Enrolling 30,000 Patients For Coronavirus Vaccine Trial [Video]](https://video.newsserve.net/300/v/20201022/2010221711-Moderna-Finishes-Enrolling-30-000-Patients-For-Coronavirus.jpg)
